Clinical Trial Update: Study of Safety and Efficiency of the Drug Reamberin® in the Intensive Care of Patients With Acute Ethanol Intoxication

View source ↗

Summary

This clinical trial update reports safety and efficacy findings for Reamberin in the intensive care management of patients with acute ethanol intoxication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ethanol Intoxication

Drugs mentioned

• Reamberin

Snippet

Sponsor: POLYSAN Scientific & Technological Pharmaceutical Company | Conditions: Ethanol Intoxication | Status: COMPLETED